June 19, 2017 / 3:46 PM / 3 months ago

GSK to get new pharma head in Sept, after AstraZeneca tussle

LONDON, June 19 (Reuters) - GlaxoSmithKline said on Monday it had reached an agreement for Luke Miels to start as its new head of pharmaceuticals on Sept. 4, following a drawn-out dispute over his contract with former employer AstraZeneca. (Reporting by Ben Hirschler; Editing by Kate Kelland)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below